Sarepta Therapeutics, Inc.

By person

30 insiders · 178 transactions

13.5×

Douglas S. Ingram holds 13.5 times base salary in stock. $15.82M of shares against $1.17M in salary for 2025.

Salary from the company's own proxy. The shares are what Douglas S. Ingram last reported holding, valued at $17.02, the price Common Stock was last bought or sold at on the open market here, on 12 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mahatme Sandesh

EVP, CFO & CBO

—

$50.87M (9) scheduled

−$50.87M

44,284

0.0419%

$753.71K

+131.7%

Howton David T

EVP, General Counsel

—

$43.31M (17) scheduled

−$43.31M

31,871

0.0302%

$542.44K

+906.0%

Chambers Michael Andrew

Director

$23.27M (14)

—

+$23.27M

311,569

0.2950%

$5.30M

+314.4%

INGRAM DOUGLAS S

Chief Executive Officer

$14.02M (12)

—

+$14.02M

929,391

0.8799%

$15.82M

—

Barry Richard

Director

$5.49M (7)

$18.77M (5)

−$13.28M

3,123,542

2.96%

$53.16M

0.0%

Cumbo Alexander

EVP, Chief Commercial Officer

—

$12.25M (8) scheduled

−$12.25M

12,008

0.0114%

$204.38K

−40.8%

Wigzell Hans Lennart Rudolf

Director

—

$11.03M (15) scheduled

−$11.03M

42,098

0.0399%

$716.51K

+643.0%

Brown Ryan Edward

EVP, General Counsel

—

$6.55M (8) scheduled

−$6.55M

17,129

0.0162%

$291.54K

+286.5%

Kaye Edward M. MD

Director

—

$4.04M (5) scheduled

−$4.04M

71,229

0.0674%

$1.21M

−7.5%

Arif Bilal

Chief Tech Ops Officer

—

$2.18M (8) scheduled

−$2.18M

32,500

0.0308%

$553.15K

+37.5%

Ruff Shamim

SVP, Chief Regulatory Affairs

—

$2.09M (6) scheduled

−$2.09M

31,936

0.0302%

$543.55K

+85.3%

Aphale Jayant

VP, Technical Operations

—

$1.75M (2) scheduled

−$1.75M

11,490

0.0109%

$195.56K

0.0%

BEHRENS M KATHLEEN

Director

$219.95K (1)

$1.75M (2) scheduled

−$1.53M

224,357

0.2124%

$3.82M

+85.2%

Estepan Ian Michael

Chief Operating Officer

—

$1.27M (3)

−$1.27M

177,184

0.1677%

$3.02M

+1,225%

Mayo Stephen

Director

—

$603.00K (3)

−$603.00K

18,640

0.0176%

$317.25K

—

Bratica Joseph

Principal Financial Officer

—

$538.35K (3) scheduled

−$538.35K

8,140

0.0077%

$138.54K

0.0%

Murray Dallan

Chief Customer Officer

—

$508.90K (1) scheduled

−$508.90K

38,202

0.0362%

$650.20K

+74.0%

Rodino-Klapac Louise

President, R&D and Tech Ops

$299.87K (1)

—

+$299.87K

203,900

0.1930%

$3.47M

+2,430%

Boor Kathryn Jean

Director

—

$298.95K (2)

−$298.95K

25,138

0.0238%

$427.85K

—

Nicaise Claude

Director

—

$248.20K (1) scheduled

−$248.20K

48,407

0.0458%

$823.89K

+4,741%

BONNEY MICHAEL W

Director

$173.48K (1)

—

+$173.48K

9,126

0.0086%

$155.32K

—

SEVERINO MICHAEL

Chief Executive Officer

—

756,104

0.7158%

$12.87M

—

Wong Ryan Ho-Yan

Chief Financial Officer

—

121,792

0.1153%

$2.07M

+589.8%

Rothfuss Cristin

EVP, General Counsel

—

115,519

0.1094%

$1.97M

+738.4%

O'Neill Gilmore Neil

EVP, R&D & CMO

—

29,070

0.0275%

$494.77K

—

Connelly Deirdre P

Director

—

22,100

0.0209%

$376.14K

—

Ciambrone William

EVP

—

22,099

0.0209%

$376.12K

+8,432%

GRAY MARY ANN

Director

—

12,356

0.0117%

$210.30K

+18,071%

MARTIN JOHN C

Director

—

7,913

0.0075%

$134.68K

—

Kress Jean-Paul

Director

—

2,000

0.0019%

$34.04K

+100.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Chambers Michael Andrew

16 Aug 2024

Director

Buy indirect

5,648

$134.66

$760.56K

Chambers Michael Andrew

16 Aug 2024

Director

Buy indirect

18,284

$134.06

$2.45M

Chambers Michael Andrew

16 Aug 2024

Director

Buy indirect

13,106

$133.07

$1.74M

INGRAM DOUGLAS S

3 Nov 2023

President & CEO

Buy

200

$81.26

$16.25K

INGRAM DOUGLAS S

3 Nov 2023

President & CEO

Buy

3,884

$80.33

$312.00K

INGRAM DOUGLAS S

3 Nov 2023

President & CEO

Buy

11,060

$79.70

$881.48K

INGRAM DOUGLAS S

3 Nov 2023

President & CEO

Buy

10,081

$78.57

$792.06K

Barry Richard

3 Nov 2023

Director

Buy indirect

40,000

$78.81

$3.15M

Barry Richard

3 Nov 2023

Director

Buy indirect

10,000

$78.81

$788.10K

Chambers Michael Andrew

14 Aug 2023

Director

Buy indirect

4,032

$109.89

$443.08K

Chambers Michael Andrew

14 Aug 2023

Director

Buy indirect

5,947

$109.19

$649.35K

Chambers Michael Andrew

11 Aug 2023

Director

Buy indirect

23,686

$108.05

$2.56M

Chambers Michael Andrew

10 Aug 2023

Director

Buy indirect

31,570

$106.26

$3.35M

Chambers Michael Andrew

10 Aug 2023

Director

Buy indirect

1,091

$105.90

$115.54K

Chambers Michael Andrew

10 Aug 2023

Director

Buy indirect

2,206

$104.67

$230.90K

Chambers Michael Andrew

14 Sep 2022

Director

Buy

6,250

$105.16

$657.25K

Chambers Michael Andrew

14 Sep 2022

Director

Buy

30,106

$104.67

$3.15M

Chambers Michael Andrew

14 Sep 2022

Director

Buy

20,744

$103.87

$2.15M

Chambers Michael Andrew

19 Aug 2022

Director

Buy

6,060

$108.80

$659.33K

Chambers Michael Andrew

19 Aug 2022

Director

Buy

40,110

$108.20

$4.34M

Rodino-Klapac Louise

24 Nov 2021

Head of R&D, CSO

Buy

3,780

$79.33

$299.87K

INGRAM DOUGLAS S

17 Nov 2021

President & CEO

Buy

25,026

$79.94

$2.00M

Barry Richard

13 Sep 2019

Director

Buy

3,309

$87.49

$289.50K

Barry Richard

12 Sep 2019

Director

Buy

1,691

$87.49

$147.95K

BONNEY MICHAEL W

9 Sep 2019

Director

Buy

2,000

$86.74

$173.48K

BEHRENS M KATHLEEN

6 Sep 2019

Director

Buy

2,500

$87.98

$219.95K

Barry Richard

20 Aug 2019

Director

Buy

5,000

$99.32

$496.59K

Barry Richard

14 Aug 2019

Director

Buy

3,700

$122.50

$453.25K

INGRAM DOUGLAS S

12 Aug 2019

President & CEO

Buy

7,792

$123.41

$961.61K

INGRAM DOUGLAS S

12 Aug 2019

President & CEO

Buy

8,460

$122.76

$1.04M

Barry Richard

12 Aug 2019

Director

Buy

1,300

$122.50

$159.25K

INGRAM DOUGLAS S

30 Oct 2018

President & CEO

Buy

3,134

$120.94

$379.03K

INGRAM DOUGLAS S

30 Oct 2018

President & CEO

Buy

13,561

$120.26

$1.63M

INGRAM DOUGLAS S

15 Aug 2018

President & CEO

Buy

16,000

$125.26

$2.00M

INGRAM DOUGLAS S

8 Nov 2017

President & CEO

Buy

38,138

$52.44

$2.00M

INGRAM DOUGLAS S

27 Jul 2017

President & CEO

Buy

47,058

$42.50

$2.00M

Show all 178 transactions →

Sarepta Therapeutics, Inc.

By person

Individual transactions

What was left out